Published on in Vol 2, No 2 (2018): Jul-Dec

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/9935, first published .
The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing

The iPrevent Online Breast Cancer Risk Assessment and Risk Management Tool: Usability and Acceptability Testing

Louisa L Lo   1 , MBChB (Hons), FRACP ;   Ian M Collins   2 , MBBchBAO, MSc, DMedSci ;   Mathias Bressel   3 , BSc, MSc ;   Phyllis Butow   4 , PhD ;   Jon Emery   5, 6 , MBBCh, MA, DPhil ;   Louise Keogh   7 , PhD ;   Prue Weideman   1, 8 , GradDip (HlthProm) ;   Emma Steel   7 , BSc, MGenCouns ;   John L Hopper   8 , BA, BSc, MSc, PhD ;   Alison H Trainer   9, 10 , MBChB, BSc, MSc, PhD ;   Gregory B Mann   11 , MBBS, PhD, FRACS ;   Adrian Bickerstaffe   8 , DPhil ;   Antonis C Antoniou   12 , PhD ;   Jack Cuzick   13 , PhD ;   Kelly-Anne Phillips   1, 8, 10 , MBBS (Hons), MD

1 Department of Medical Oncology, Peter MacCallum Cancer Centre, Victoria, Australia

2 School of Medicine, Deakin University, Geelong, Australia

3 Centre for Biostatistics and Clinical Trials, Peter MacCallum Cancer Centre, Melbourne, Australia

4 Centre for Medical Psychology & Evidence-Based Decision-Making, University of Sydney, Sydney, Australia

5 Department of General Practice and the Centre for Cancer Research, The University of Melbourne, Melbourne, Australia

6 School of Primary, Aboriginal and Rural Health Care, University of Western Australia, Perth, Australia

7 Centre for Health Equity, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

8 Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, Australia

9 Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Australia

10 The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, Australia

11 Department of Surgery, The University of Melbourne, Melbourne, Australia

12 Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom

13 Centre for Cancer Prevention, Wolfson Institute of Preventive Medicine, Queen Mary University of London, London, United Kingdom

Corresponding Author:

  • Kelly-Anne Phillips, MBBS (Hons), MD
  • Department of Medical Oncology
  • Peter MacCallum Cancer Centre
  • Locked Bag 1, A'Beckett Street
  • Victoria, 8006
  • Australia
  • Phone: 61 3 85597860
  • Fax: 61 3 85597739
  • Email: Kelly.Phillips@petermac.org